LUMOS PHARMA, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.87 USD | -1.03% |
|
-4.33% | -9.75% |
| Mar. 07 | Lumos Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 07 | Transcript : Lumos Pharma, Inc., 2023 Earnings Call, Mar 07, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 23.54M | - | - | - | |||
| 44.96B | - | |||||
| 42.65B | ||||||
| 41.85B | ||||||
| 29.04B | ||||||
| 26.08B |
- Stock Market
- Equities
- LUMO Stock
- Charts Lumos Pharma, Inc.
- Sector Chart